Bot KK, Ezzafzafi S, Lantinga MA. Not all DOACs are created equal, revisiting the safety of rivaroxaban for the prevention of portal hypertension-related complications. J Hepatol 2025 Aug 5:S0168-8278(25)02396-7. doi: 10.1016/j.jhep.2025.
PMID: 40774627